NUS Links:
Glioblastoma (GBM) is the most aggressive form of solid brain tumours with limited treatment options. Nanoparticles have been shown to induce an antitumour effect and target GBM selectively. Researchers in this study, which includes N2CR member Dr Derrick Ong, provides evidence for the possible application of nanoparticles to treat GBM and other advanced-stage solid tumours.
Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof …
Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …
Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is dismal. A recent experimental treatment …